1589 related articles for article (PubMed ID: 8450208)
1. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
2. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
Owens T; Fazekas de St Groth B
J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
[TBL] [Abstract][Full Text] [Related]
3. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
4. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
Boyce NW; Jönsson JI; Emmrich F; Eichmann K
J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
[TBL] [Abstract][Full Text] [Related]
5. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
[TBL] [Abstract][Full Text] [Related]
6. T cell receptor aggregation, but not dimerization, induces increased cytosolic calcium concentrations and reveals a lack of stable association between CD4 and the T cell receptor.
Ratcliffe MJ; Coggeshall KM; Newell MK; Julius MH
J Immunol; 1992 Mar; 148(6):1643-51. PubMed ID: 1531842
[TBL] [Abstract][Full Text] [Related]
7. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC.
Yagi J; Baron J; Buxser S; Janeway CA
J Immunol; 1990 Feb; 144(3):892-901. PubMed ID: 2136903
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
St Pierre Y; Watts TH
J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
[TBL] [Abstract][Full Text] [Related]
9. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
10. Two roles for Ia in antigen-specific T cell activation. II. Toward a Velcro model of antigen recognition.
Kim KH; Thomas DW
J Immunol; 1988 Apr; 140(8):2500-7. PubMed ID: 3258611
[TBL] [Abstract][Full Text] [Related]
11. The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells.
Kimachi K; Croft M; Grey HM
Eur J Immunol; 1997 Dec; 27(12):3310-7. PubMed ID: 9464819
[TBL] [Abstract][Full Text] [Related]
12. Functionally active T cell receptor/CD3 complexes are present at the surface of cloned cytotoxic T cells without fluorescence-immunological detectability.
Staege MS; Dick T; Reske-Kunz AB
Cell Immunol; 1996 Jul; 171(1):62-7. PubMed ID: 8660838
[TBL] [Abstract][Full Text] [Related]
13. T cell activation by a bispecific anti-CD3/anti-major histocompatibility complex class I antibody.
Roosnek E; Tunnacliffe A; Lanzavecchia A
Eur J Immunol; 1990 Jun; 20(6):1393-6. PubMed ID: 2142461
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
[TBL] [Abstract][Full Text] [Related]
15. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
16. TCR-gamma delta cells in CD3 zeta-deficient mice contain Fc epsilon RI gamma in the receptor complex but are specifically unresponsive to antigen.
Khattri R; Sperling AI; Qian D; Fitch FW; Shores EW; Love PE; Bluestone JA
J Immunol; 1996 Sep; 157(6):2320-7. PubMed ID: 8805629
[TBL] [Abstract][Full Text] [Related]
17. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
Sant AJ
J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
[TBL] [Abstract][Full Text] [Related]
18. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
19. Direct activation of murine resting T cells by con A or anti-CD3 Ig.
Quintáns J; Yokoyama A; Evavold B; Hirsch R; Mayforth RD
J Mol Cell Immunol; 1989; 4(4):225-35; discussion 235-7. PubMed ID: 2532886
[TBL] [Abstract][Full Text] [Related]
20. Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)/stem cell antigen-2 (Sca-2).
Saitoh S; Kosugi A; Noda S; Yamamoto N; Ogata M; Minami Y; Miyake K; Hamaoka T
J Immunol; 1995 Dec; 155(12):5574-81. PubMed ID: 7499840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]